# Implantation or Injectable Dosage Form New Animal Drugs; Insulin
> **Food and Drug Administration** · Final rule. · Published 2009-12-14 · Effective 2009-12-14 · 74 FR 66047
## Document
- **Document number:** E9-29583
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 74 FR 66047
- **CFR reference:** 21 CFR 522
- **Publication date:** 2009-12-14
- **Effective date:** 2009-12-14
- **HHS docket:** Docket No. FDA-2009-N-0665
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an original new animal drug application (NADA) filed by Boehringer Ingelheim Vetmedica, Inc. The NADA provides for veterinary prescription use of an injectable suspension of protamine zinc recombinant human insulin for the reduction of hyperglycemia and hyperglycemia-associated clinical signs in cats with diabetes mellitus.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2009/12/14/E9-29583/implantation-or-injectable-dosage-form-new-animal-drugs-insulin)
---
*AI Analytics · CC0 1.0*